Turmeric and Compatibility with Chemotherapy

Turmeric is increasingly being shown to have favorable influences on various cancer treatments, primarily through its ability to increase rates of apoptosis and with its unique effects on AMPK levels.  Numerous investigations within the field of oncology have demonstrated improved chemosensitivity and reduced chemoresistance in tumors with co-treatments of turmeric and chemoagents such as DFMO, a polyamine regulating drug, cisplatin, and others that target DNA damage.  These favorable interactions increase the effectiveness of chemotherapy interventions with lymphoma, colorectal, glioblastoma, and breast cancers, among others (1,2,3). Continue reading